Monoclonal Antibody Treatment for COVID-19
Did you know there are free treatment options for eligible COVID-19 positive patients? FDA-authorized monoclonal antibody treatments can help boost your immune response, keeping you out of the hospital. With thousands of infusion and injection sites available across the country, these treatments typically take 16 minutes to an hour followed by an hour observation.
If you have tested positive for COVID-19, getting treated may help keep you out of the hospital, but you must act fast. Patients can only receive monoclonal antibody therapies within 10 days of the onset of symptoms. Talk to your healthcare provider to learn more.
Check here for more information from the TN Department of Health: Monoclonal Therapy
Monoclonal Antibody for Post-Exposure Prophylaxis
September 2021
Update: The TN Board of Health has stated that monoclonal antibodies may not be used for post-exposure prophylaxis at this time due to the state’s logistical constraints.
- Guidelines for prioritization of monoclonal antibody therapy: Statement on Prioritization of Anti-SARS-CoV-2 Monoclonal Antibodies | COVID-19 Treatment Guidelines (nih.gov)
August 2021:
The FDA has authorized the monoclonal antibody, REGEN-COV, for emergency use as post-exposure prophylaxis (prevention) for COVID-19 in adults and pediatric individuals (12 years of age and older weighing at least 40 kg) who are at high risk for progression to severe COVID-19, including hospitalization or death.
REGEN-COV is not authorized for pre-exposure prophylaxis to prevent COVID-19 before being exposed to the SARS-CoV-2 virus — only after exposure to the virus.
